Serum interleukin-6 in congestive heart failure secondary to idiopathic dilated cardiomyopathy
The American Journal of Cardiology
|September 11, 1998
Insights
Elevated serum interleukin-6 (IL-6) indicates a poorer prognosis in heart disease patients. Higher IL-6 levels correlate with worse heart function and increased disease progression, highlighting its role in cardiovascular health.
Area of Science:
- Cardiology
- Immunology
- Biomarkers
Background:
- Interleukin-6 (IL-6) is a pro-inflammatory cytokine implicated in various diseases.
- The prognostic value of serum IL-6 in cardiovascular disease requires further elucidation.
Purpose of the Study:
- To investigate the association between serum IL-6 levels and clinical outcomes in patients with heart conditions.
- To determine if elevated IL-6 predicts disease progression and impaired cardiac function.
Main Methods:
- Serum samples were collected to measure IL-6 concentrations.
- New York Heart Association (NYHA) functional class and left ventricular function were assessed during follow-up.
Main Results:
- Increased serum IL-6 levels were significantly associated with higher NYHA functional classes (III-IV).
- Elevated IL-6 correlated with worse left ventricular function over time.
- Patients with higher serum IL-6 exhibited a poorer overall prognosis.
Conclusions:
- Serum IL-6 is a potential biomarker for predicting poor prognosis in cardiovascular disease.
- Elevated IL-6 levels may contribute to disease progression and functional decline.
- Targeting IL-6 pathways could be a therapeutic strategy for improving cardiovascular outcomes.
Abstract:
Increased serum interleukin-6 (IL-6) was associated with a higher incidence of New York Heart Association functional classes III to IV and worse left ventricular function during follow-up. Patients with elevated serum IL-6 had poor prognosis. These results reinforce the concept that increased serum IL-6 may also play an important role in disease progression.
Related Concept Videos
01:26Imbalances in Cardiac Output
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
01:29Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
01:26Heart Failure III: Clinical Manifestations
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...